Yeungnam Univ J Med Search


Yeungnam Univ J Med > Volume 33(2); 2016 > Article
Yeungnam University Journal of Medicine 2016;33(2):150-154.
DOI:    Published online December 31, 2016.
Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation.
Min Gue Seok, Tae Hee Lee, Sung Ro Yun, Won Min Hwang, Se Hee Yoon, In Soo Choe, Seong Joo Kang, Ju Young Hong, Dae Sung Kim
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.
Key Words: Kidney transplantation, Chronic hepatitis C, Ribavirin, Peginterferon alpha
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  • 795 View
  • 0 Download
Related articles in Yeungnam Univ J Med


Browse all articles >

Editorial Office
170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea
Tel: +82-53-640-6832    Fax: +82-53-651-0394    E-mail:                

Copyright © 2021 by Yeungnam University College of Medicine.

Developed in M2PI

Close layer
prev next